Lotus Pharmaceuticals (LTUS)
0.005
0.00 (0.00%)
USD |
OTCM |
Apr 29, 16:00
Lotus Pharmaceuticals Net Income (Quarterly): -0.0044M for Sept. 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -0.0044M |
Date | Value |
---|---|
September 30, 2022 | -0.0014M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-0.0044M
Minimum
Sep 2023
-0.0014M
Maximum
Sep 2022
-0.0029M
Average
-0.0029M
Median
Net Income (Quarterly) Benchmarks
Quantum Fintech Acquisition Corp (DELISTED) | -0.256M |
BlueRiver Acquisition Corp | -0.8191M |
Jaws Mustang Acquisition Corp | -0.4945M |
Bite Acquisition Corp | 0.229M |
Williams Rowland Acquisition Corp (DELISTED) | -0.0222M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 0.0044M |
Enterprise Value | 0.2483M |